Medical Science News

RSS

Temple researchers receive NIAID grant to study immunological synapse formation

Switching immune cells on is a critical step in combating infection. In the case of T cells, which are key players in immunity, this happens when dormant T cells circulating in the blood encounter a suspicious agent on the surface of specialized antigen-presenting cells.

14 Apr 2020

Researchers develop synthetic scaffolds for tendon and ligament regeneration

Australia's love of sport means it has one of the highest rates of knee anterior cruciate ligament (ACL) injury and reconstruction in the world.

14 Apr 2020

Research shows how stress changes structure of the brain

Research led by Si-Qiong June Liu, MD, Ph.D., Professor of Cell Biology and Anatomy at LSU Health New Orleans School of Medicine, has shown how stress changes the structure of the brain and reveals a potential therapeutic target to the prevent or reverse it

14 Apr 2020

Experimental drug could stop tumor relapse, mice study shows

A drug that is well-tolerated in patients and prevents cancer coming back in mice has been identified by researchers at the Francis Crick Institute.

14 Apr 2020

Mediterranean diet correlates with higher cognitive function

According to a recent analysis of data from two major eye disease studies, adherence to the Mediterranean diet - high in vegetables, whole grains, fish, and olive oil - correlates with higher cognitive function.

14 Apr 2020

New mathematical model can help explain why so many pregnancies and IVF attempts fail

Scientists have created a mathematical model that can help explain why so many pregnancies and in vitro fertilization attempts fail.

13 Apr 2020

Tumors commandeer cell death pathway to avoid immune system attack after radiation

Cancer cells avoid an immune system attack after radiation by commandeering a cell signaling pathway that helps dying cells avoid triggering an immune response, a new study led by UTSW scientists suggests.

13 Apr 2020

Ebola drug effective against key enzyme of coronavirus that causes COVID-19

Scientists at the University of Alberta have shown that the drug remdesivir is highly effective in stopping the replication mechanism of the coronavirus that causes COVID-19, according to new research published today in the Journal of Biological Chemistry.

13 Apr 2020

New 3D imaging technique helps researchers watch neural activity in real time

Our ability to study networks within the nervous system has been limited by the tools available to observe large volumes of cells at once.

13 Apr 2020

Study highlights triptolide as valuable therapeutic approach for IDH1-mutated glioma

Findings of a new study led by Prof. XU Guowang from the Dalian Institute of Chemical Physics of the Chinese Academy of Sciences and Prof. YANG Chunzhang from the National Cancer Institute shed light on the selective therapeutics for IDH1-mutated glioma by targeting glutathione synthesis pathway.

13 Apr 2020

Could DPP4 inhibitors help treat COVID-19?

Researchers and clinicians are scrambling to find ways to combat COVID-19, including new therapeutics and eventually a vaccine.

13 Apr 2020

Adapting smartwatches to deliver information about brain states

As schools and universities around the globe pivot to online teaching, and millions of students stare at screens during their school day, it is hard to imagine a personalized learning experience.

13 Apr 2020

Exercise enhances muscle-repair capabilities in old mice, Stanford study shows

A nightly jaunt on the exercise wheel enhances muscle-repair capabilities in old mice, according to a new study by researchers at Stanford School of Medicine.

13 Apr 2020

RIT faculty receives NSF CAREER award to to study how human visual system perceives AR

A Rochester Institute of Technology faculty member received a prestigious National Science Foundation award to research how the human visual system perceives a mix of augmented reality and real-world content.

13 Apr 2020

FDA approves new Rutgers saliva test for coronavirus

The FDA has granted emergency use authorization to Rutgers' RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency.

13 Apr 2020